drugset / Trial / NCT03767920
Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing an elective Caesarean section. * Group 1: bupivacaine 0.25% + dexamethasone 8 mg * Group 2: bupivacaine 0.25% A prospective Randomized Interventional double-blind study.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-03-30
- Completion
- 2020-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexamethasone | Small molecule | 4 mg | Other |
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Bupivacaine | Other / unclassified | 20 ml | Other |
Indications
No indication recorded.